Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
about
Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural AnalysisSuperior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.Production of avian influenza virus vaccine using primary cell cultures generated from host organs.Bacterially produced recombinant influenza vaccines based on virus-like particles.A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimenQ&A: What do we know about influenza and what can we do about it?Comparative pathology of select agent influenza a virus infections.The future of cell culture-based influenza vaccine production.RNA replicons - a new approach for influenza virus immunoprophylaxis.Evasion of influenza A viruses from innate and adaptive immune responses.Egg-Independent Influenza Vaccines and Vaccine CandidatesInfluenza virus assays based on virus-inducible reporter cell lines.Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice.
P2860
Q26783481-09F67353-8A76-4A47-B83C-1E415361CEE3Q27673887-B2400DC3-F979-42C3-9B83-51FAF9FA51F4Q30365243-EF9CEEB7-A265-477E-858E-54E7A3BA54E5Q30382650-2A43A34A-FAF1-437A-AC92-C797AD0188E7Q30389274-3C496477-2BE5-4111-B977-DCF5667F1D81Q30428538-1C772546-E390-461A-B414-918AF9B3220AQ35048127-1CB21D76-16DA-4D03-9081-4686EF5A5C68Q35474243-6D1F532E-C4BD-45A0-B101-0887AB89B9AFQ36456190-A11A4812-4E03-4796-9B85-E33EFF9F1D8FQ37330237-DAB221B1-1A56-49AB-9761-83D3C48DA868Q37777544-C0509C45-CBE2-4DBF-8385-953233CEAB45Q37919896-F2EFDFF6-4FB5-4D8C-9516-C7866BF9C01CQ37945198-A34A441A-63D6-48E4-8EBC-94C4A82D1710Q38061423-0D3A2B67-9503-4F08-B7B3-E928C22261F6Q39441518-B08694C7-AC68-48D9-A8E9-6A4BD7F80A31Q39806885-F0AFC403-BE82-4867-BD50-E685CABFFDE9Q45325947-39B1C02E-D6BB-44DA-BA9D-00327E50B7C1
P2860
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vaccination strategies and vac ...... nd pandemic influenza control.
@ast
Vaccination strategies and vac ...... nd pandemic influenza control.
@en
type
label
Vaccination strategies and vac ...... nd pandemic influenza control.
@ast
Vaccination strategies and vac ...... nd pandemic influenza control.
@en
prefLabel
Vaccination strategies and vac ...... nd pandemic influenza control.
@ast
Vaccination strategies and vac ...... nd pandemic influenza control.
@en
P356
P1433
P1476
Vaccination strategies and vac ...... nd pandemic influenza control.
@en
P2093
Joost H C M Kreijtz
P304
P356
10.4161/HV.5.3.6986
P577
2009-03-15T00:00:00Z